TERT Promoter Variants and Age: Refining Prognostic Precision in Papillary Thyroid Carcinoma
Highlight
– The prevalence of TERT promoter variants increases significantly with patient age in papillary thyroid carcinoma (PTC), being rare under 30 years and common over 65 years.
– In patients younger than 55 without TERT mutations, disease-specific survival (DSS) at 10 years approaches 100%.
– Among patients 55 years or older, those with TERT promoter variants have a markedly worse 10-year DSS (51%) compared to TERT wild-type (91%).
– TERT promoter mutational status independently predicts prognosis beyond conventional age and tumor-node-metastasis (TNM) staging, suggesting potential to enhance risk stratification.
Study Background
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.